Skip to content

Recent
Transactions

We represent foreign and domestic clients in a broad range of capital raising, M&A and other corporate transactions. Below are tombstone listings of certain of our recent representative transactions. Please click on a tombstone for a description of the specific deal.

All
  • All
  • Cryptocurrency
  • IPOs and Public Offerings
  • M&A
  • Other
  • PIPES and Private Placements
  • Private Fund
  • SPAC

BioSig Technologies, Inc. $3,000,000

Registered Direct Offering

May 2024

Press Release ›

BriaCell Therapeutics Corp. $5,000,000

Registered Direct Offering

May 2024

Press Release ›

Siyata Mobile $4,000,000

Public Offering

May 2024

Press Release ›

INmune Bio Inc. $9,700,000

Registered Direct Offering

April 2024

Press Release ›

INmune Bio Inc. $4,800,000

Registered Direct Offering

April 2024

Press Release ›

Genetic Technologies Limited $2,000,000

Registered Direct Offering

April 2024

Press Release ›

NRx Pharmaceuticals, Inc. $2,000,000

Common Stock Offering

April 2024

Press Release ›

Serve Robotics Inc. $40,000,000

Common Stock Offering

April 2024

Press Release ›

Safety Shot, Inc. $5,000,000

Private Placement

April 2024

Press Release ›

A2Z Smart Technologies Corp. $5,700,000

Registered Direct Offering

Private Placement

Press Release ›

Applied UV, Inc. $2,760,000

Registered Direct Offering

March 2024

Press Release ›

Beyond Air, Inc. $16,000,000

Registered Direct Offering

March 2024

Press Release ›

ShiftPixy, Inc. $5,000,000

Public Offering

March 2024

Press Release ›

C3is Inc. $6,000,000

Common Stock

March 2024

Press Release ›

Nature’s Miracle, Inc.

Business Combination

March 2024

Press Release ›

NRx Pharmaceuticals $1,500,000

Common Stock and Warrants

February 2024

Press Release ›

Vocodia Holdings Corp. $6,000,000

Initial Public Offering

February 2024

Press Release ›

Cel-Sci Corp. $7,750,000

Initial Public Offering

February 2024

Press Release ›

Lexaria Bioscience Corp. $3,600,000

Registered Direct Offering

February 2024

Press Release ›

Sunshine Biopharma, Inc. $10,000,000

Common Stock and Warrants

February 2024

Press Release ›